ACE and COVID-19: In this study, the role of angiotensin-converting enzyme (ACE) and angiotensin II (ANG II) plasma levels on disease prognosis and mortality was investigated in isolated-hypertensive (HT) patients, patients with chronic disease in addition to hypertension and COVID-19 patients without comorbidity.